American journal of ophthalmology
Audio Summaries

Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic Uveitis

Jun 23, 2026

The authors aimed to investigate the relationship between routine vaccinations and the risk of new-onset idiopathic uveitis (NIU). Their retrospective cohort study found that various vaccinations, including those for COVID-19, HPV, and varicella, were associated with a significant reduction in the incidence of NIU within 12 months post-vaccination. These findings suggest a potential protective effect of vaccinations against the development of NIU, highlighting the complex interactions between immune modulation and uveitis.

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation

Jun 23, 2026

This study investigates whether dopamine-enhancing therapies, specifically levodopa ± carbidopa and dopamine receptor D2 (DRD2) agonists, are associated with a reduced risk of conversion from non-neovascular age-related macular degeneration (AMD) to neovascular AMD (nAMD). The findings indicate that levodopa ± carbidopa users experienced a significantly lower risk of conversion compared to matched controls, while no significant difference was observed for DRD2 agonist users. These results suggest that dopaminergic signaling may play a role in AMD progression, highlighting the need for further prospective research.

Therapeutic response to anti-VEGF retreatment among eyes with stabilized vision after being lost to follow-up in diabetic macular edema: A nationwide, registry-based cohort study

Jun 22, 2026

The authors aimed to investigate the visual and anatomical outcomes of restarting anti-VEGF therapy in patients with diabetic macular edema (DME) who returned with stabilized vision after being lost to follow-up. They found that while a significant proportion of patients with vision decline showed improvement, those with stabilized vision had suboptimal responses, with many not gaining visual acuity despite anatomical improvements. The study suggests that the decision to retreat these patients should be made cautiously, considering the potential need for alternative therapies.

Association between statin use and dry eye disease: A systematic review and meta-analysis

Jun 22, 2026

This systematic review and meta-analysis aimed to clarify the association between statin use and dry eye disease (DED), given mixed evidence from individual studies. The analysis of six observational studies involving over 560,000 participants found a statistically significant association, indicating that statin users had a 10.2 additional cases of DED per 1,000 individuals, although the evidence was of very low certainty. The authors recommend that healthcare providers monitor ocular surface symptoms in patients on statins, especially those with pre-existing DED risk factors.

Association between 24-Hour Blood Pressure and Rates of Retinal Nerve Fiber Layer Progression in Glaucoma: The Vascular Imaging in Glaucoma Study

Jun 21, 2026

The authors aimed to investigate the relationship between 24-hour blood pressure (BP) and the rate of retinal nerve fiber layer (RNFL) loss in patients with primary open-angle glaucoma (POAG). Their findings indicate that lower systemic BP, particularly minimum mean arterial pressure (MAP), systolic BP, and diastolic BP, is associated with accelerated RNFL loss, suggesting that 24-hour BP monitoring could be a valuable tool for identifying glaucoma patients at higher risk of progression.

Zeb1 mediates injury-induced mesenchymal transition in the mouse corneal endothelium in vivo

Jun 21, 2026

The authors investigate the role of Zeb1 in mediating injury-induced mesenchymal transition in the corneal endothelium and its contribution to fibrosis. They demonstrate that targeting Zeb1 through conditional knockout in a mouse model significantly inhibits the expression of mesenchymal transition-related genes and reduces corneal edema and retrocorneal membrane formation following injury. These findings suggest that ZEB1 signaling could be a potential therapeutic target for treating corneal blindness without the need for transplantation.

Association of the Charlson Comorbidity Index with one-year outcomes in patients with macular edema secondary to retinal vein occlusion

Jun 19, 2026

The authors aimed to assess the predictive value of the Charlson Comorbidity Index (CCI) on visual and anatomical outcomes in patients with macular edema secondary to retinal vein occlusion (RVO). Their findings indicate that higher CCI scores correlate with poorer best-corrected visual acuity outcomes, particularly in patients with more comorbidities, while baseline central subfield thickness was a stronger predictor of final thickness outcomes across all comorbidity levels.

Axial Length Adjustment and AL/R Ratio Optimization of IOL Power Calculation in Extremely Long Eyes

Jun 19, 2026

The authors aimed to evaluate the accuracy of modern intraocular lens (IOL) power calculation formulas and axial length (AL) adjustment methods in eyes with an AL of 30.0 mm or greater. They found that the Holladay 1 formula combined with the Wang-Koch axial length adjustment provided the best predictive accuracy, while the AL-to-corneal radius (AL/R) ratio emerged as a significant factor influencing prediction errors across various formulas. This study highlights the importance of using appropriate methods for IOL power calculation in extremely long eyes to improve surgical outcomes.

Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up

Jun 17, 2026

In this reply, the authors address comments regarding their previous findings on visual field progression in glaucoma patients who experienced delayed follow-up. They aim to clarify the implications of their research and reinforce the importance of timely monitoring in managing glaucoma progression.

SEARCHING FOR NEW GENES THAT CAUSE USHER SYNDROME

Jun 17, 2026

The authors aimed to identify novel candidate genes associated with Usher syndrome (USH) by analyzing phenotyping data from 9,139 knockout mouse lines. They discovered 18 genes linked to both hearing abnormalities and retinopathy, suggesting potential roles in the pathology of USH. The findings highlight the need for further investigation into these genes to understand their contributions to retinal degeneration and hearing loss in humans.